Safety and immunogenicity of diphtheria-tetanus-acellular pertussis vaccine adsorbed , Connaught diphtheria-tetanus-acellular pertussis vaccine adsorbed , and diphtheria-tetanus-pertussis vaccine adsorbed in 2,4, and 6 month old infants
Bernstein, H.H.; Garrison, K.; Marchant, C.D.
Pediatric Research 41(4 Part 2): 117A
1997
ISSN/ISBN: 0031-3998
Accession: 033289376
PDF emailed within 1 workday: $29.90
Related References
Podda, A.; Bona, G.; Canciani, G.; Pistilli, A.M.; Contu, B.; Furlan, R.; Meloni, T.; Stramare, D.; Titone, L.; Rappuoli, R. 1995: Effect of priming with diphtheria and tetanus toxoids combined with whole-cell pertussis vaccine or with acellular pertussis vaccine on the safety and immunogenicity of a booster dose of an acellular pertussis vaccine containing a genetically inactivated pertussis toxin in fifteen- to twenty-one-month-old children. Italian Multicenter Group for the Study of Recombinant Acellular Pertussis Vaccine Journal of Pediatrics 127(2): 238-243Langley, J.M.; Predy, G.; Guasparini, R.; Law, B.; Diaz-Mitoma, F.; Whitstitt, P.; Tapiero, B.; Dionne, M.; Tomovici, A.; Mills, E.; Halperin, S.A. 2007: An adolescent-adult formulation tetanus and diptheria toxoids adsorbed combined with acellular pertussis vaccine has comparable immunogenicity but less reactogenicity in children 4-6 years of age than a pediatric formulation acellular pertussis vaccine and diphtheria and tetanus toxoids adsorbed combined with inactivated poliomyelitis vaccine Vaccine 25(6): 1121-1125
Watson, B.; Cawein, A.; Mckee, B.L.; Hackell, J.G. 1992: Safety and immunogenicity of acellular pertussis vaccine, combined with diphtheria and tetanus as the Japanese commercial Takeda vaccine, compared with the Takeda acellular pertussis component combined with Lederle's diphtheria and tetanus toxoids in two-, four- and six-month-old infants Pediatric Infectious Disease Journal 11(11): 930-935
Campbell, N.S.; Kalman, D.D. 2019: Successful vaccination with tetanus and diphtheria and acelluar pertussis vaccine after adverse reaction to diphtheria and tetanus toxoids and acellular pertussis vaccine or diphtheria and tetanus vaccine in pediatric patients Annals of Allergy Asthma and Immunology: Official Publication of the American College of Allergy Asthma and Immunology 123(4): 409-411
Pichichero, M.E.; Badgett, J.T.; Rodgers, G.C.; McLinn, S.; Trevino-Scatterday, B.; Nelson, J.D. 1987: Acellular pertussis vaccine: immunogenicity and safety of an acellular pertussis vs. a whole cell pertussis vaccine combined with diphtheria and tetanus toxoids as a booster in 18- to 24-month old children Pediatric Infectious Disease Journal 6(4): 352-363
Iwaki, M.; Komiya, T.; Fukuda, T.; Arakawa, Y.; Takahashi, M. 2003: Collaborative study: Standardization of Japanese reference diphtheria and tetanus toxoids, (adsorbed, lot 2), for potency determination of diphtheria-tetanus- acellular pertussis combined vaccine Japanese Journal of Infectious Diseases 56(4): 183-185
Tuĭmedova, R.A. 1971: Reactivity and immunogenicity of adsorbed pertussis-diphtheria-tetanus vaccine with lowered component doses. II. Immunological effectiveness of the diphtheria, tetanus and pertussis components Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 48(2): 39-42
John, T.; Voysey, M.; Yu, L.M.; McCarthy, N.; Baudin, M.; Richard, P.; Fiquet, A.; Kitchin, N.; Pollard, A.J. 2015: Immunogenicity of a low-dose diphtheria, tetanus and acellular pertussis combination vaccine with either inactivated or oral polio vaccine compared to standard-dose diphtheria, tetanus, acellular pertussis when used as a pre-school booster in UK children: a 5-year follow-up of a randomised controlled study Vaccine 33(36): 4579-4585
Zaĭtsev, E.M.; Britsina, M.V.; Bazhanova, I.G.; Mertsalova, N.U.; Ozeretskovskaia, M.N.; Ermolova, E.V.; Plekhanova, N.G.; Mikhaĭlova, N.A.; Kolyshkin, V.A.; Zverev, V.V. 2013: Preclinical studies of an adsorbed diphtheria-tetanus-pertussis vaccine (ADTP-vaccine) with acellular pertussis component Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 6: 44-49
Dominicus, R.; Galtier, F.; Richard, P.; Baudin, M. 2014: Immunogenicity and safety of one dose of diphtheria, tetanus, acellular pertussis and poliomyelitis vaccine (Repevax®) followed by two doses of diphtheria, tetanus and poliomyelitis vaccine (Revaxis®) in adults aged ≥ 40 years not receiving a diphtheria- and tetanus-containing vaccination in the last 20 years Vaccine 32(31): 3942-3949
Dagan, R.; Igbaria, K.; Piglansky, L.; Melamed, R.; Willems, P.; Grossi, A.; Kaufhold, A. 1997: Safety and immunogenicity of a combined pentavalent diphtheria, tetanus, acellular pertussis, inactivated poliovirus and Haemophilus influenzae type b-tetanus conjugate vaccine in infants, compared with a whole cell pertussis pentavalent vaccine Pediatric Infectious Disease Journal 16(12): 1113-1121
Matheson, A.J.; Goa, K.L. 2000: Diphtheria-tetanus-acellular pertussis vaccine adsorbed (Triacelluvax; DTaP3-CB): a review of its use in the prevention of Bordetella pertussis infection Paediatric Drugs 2(2): 139-159
Dagan, R.; Igbaria, K.; Piglansky, L.; Van Brusteghem, F.; Melot, V.; Kaufhold, A. 1999: Reactogenicity and immunogenicity of reduced antigen content diphtheria-tetanus-acellular pertussis vaccines as a booster in 4-7-year-old children primed with diphtheria-tetanus-whole cell pertussis vaccine before 2 years of age Vaccine 17(20-21): 2620-2627
McNeil, S.A.; Noya, F.; Dionne, M.; Predy, G.; Meekison, W.; Ojah, C.; Ferro, S.; Mills, E.L.; Langley, J.M.; Halperin, S.A. 2007: Comparison of the safety and immunogenicity of concomitant and sequential administration of an adult formulation tetanus and diphtheria toxoids adsorbed combined with acellular pertussis (Tdap) vaccine and trivalent inactivated influenza vaccine in adults Vaccine 25(17): 3464-3474
Thierry-Carstensen, B.; Jordan, K.; Uhlving, H.H.; Dalby, T.; Sørensen, C.; Jensen, A.M.ør.; Heilmann, C. 2012: A randomised, double-blind, non-inferiority clinical trial on the safety and immunogenicity of a tetanus, diphtheria and monocomponent acellular pertussis (TdaP) vaccine in comparison to a tetanus and diphtheria (Td) vaccine when given as booster vaccinations to healthy adults Vaccine 30(37): 5464-5471